Related references
Note: Only part of the references are listed.Fructose ingestion acutely stimulates circulating FGF21 levels in humans
Jody R. Dushay et al.
MOLECULAR METABOLISM (2015)
Fibroblast growth factor 21 analogue LY2405319 lowers blood glucose in streptozotocin-induced insulin-deficient diabetic mice by restoring brown adipose tissue function
J. -H. Kim et al.
DIABETES OBESITY & METABOLISM (2015)
ANGPTL8/Betatrophin Does Not Control Pancreatic Beta Cell Expansion
Viktoria Gusarova et al.
CELL (2014)
Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes
Daniel Espes et al.
DIABETOLOGIA (2014)
FGF21-based pharmacotherapy - potential utility for metabolic disorders
Ruth E. Gimeno et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
Inventing new medicines: The FGF21 story
Alexei Kharitonenkov et al.
MOLECULAR METABOLISM (2014)
A link between hepatic glucose production and peripheral energy metabolism via hepatokines
Aya Abdul-Wahed et al.
MOLECULAR METABOLISM (2014)
被撤回的出版物: Betatrophin: A Hormone that Controls Pancreatic β Cell Proliferation (Retracted article. See vol. 168, pg. 326, 2017)
Peng Yi et al.
CELL (2013)
The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
Gregory Gaich et al.
CELL METABOLISM (2013)
The role of hepatokines in metabolism
Norbert Stefan et al.
NATURE REVIEWS ENDOCRINOLOGY (2013)
Liver-Derived Systemic Factors Drive β Cell Hyperplasia in Insulin-Resistant States
Abdelfattah El Ouaamari et al.
CELL REPORTS (2013)
Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice
Marie Anson et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance
Durba Pal et al.
NATURE MEDICINE (2012)
Circadian Rhythm of Circulating Fibroblast Growth Factor 21 Is Related to Diurnal Changes in Fatty Acids in Humans
Haoyong Yu et al.
CLINICAL CHEMISTRY (2011)
Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease
Jody Dushay et al.
GASTROENTEROLOGY (2010)
Glucose induces FGF21 mRNA expression through ChREBP activation in rat hepatocytes
Katsumi Iizuka et al.
FEBS LETTERS (2009)
Hepatic fibroblast growth factor 21 is regulated by PPARα and is a key mediator of hepatic lipid metabolism in ketotic states
Michael K. Badman et al.
CELL METABOLISM (2007)
Share Paper
